Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

12.20

+0.58 (4.99%)

At close: Sep 11, 2026, 4:00 PM EDT

12.28

+0.08 (0.66%)

After-hours: Sep 11, 2026, 7:30 PM EDT

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	416.82	478.39	519.85	615.1	905.45	1,431
Short-Term Investments	-	2.4	6.14	13.41	2.09	65.63
Cash & Short-Term Investments	416.82	480.79	525.99	628.5	907.55	1,497
Cash Growth	-7.93%	-8.59%	-16.31%	-30.75%	-39.37%	-33.84%
Accounts Receivable	182.55	181.91	165.87	149.61	151.71	134.59
Other Receivables	-	0.07	0.18	1.18	0.1	0.11
Receivables	182.55	181.98	166.05	150.79	151.81	138.2
Inventory	34.13	56.98	62.63	69.02	130.32	123.21
Restricted Cash	2.29	2.7	2.31	0.12	19.82	7.8
Other Current Assets	28.23	16.14	19.65	35.67	49.27	54.79
Total Current Assets	664.02	738.59	776.62	884.1	1,259	1,821
Property, Plant & Equipment	78.09	73.87	100.34	144.2	300.03	406.45
Long-Term Investments	-	-	-	0.34	0.69	0.91
Other Intangible Assets	0.23	0.28	0.42	0.96	1.99	5.15
Other Long-Term Assets	8.27	7.63	7.93	5.09	20.89	45.14
Total Assets	750.61	820.38	885.31	1,040	1,587	2,279

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	17.95	40.74	33.75	18.06	50.95	63.08
Accrued Expenses	68.46	51.99	56.71	65.37	104.23	107.03
Short-Term Debt	-	-	-	-	-	2.37
Current Portion of Long-Term Debt	0.2	0.2	-	-	-	-
Current Portion of Leases	21.17	16.76	24.57	8.63	37.24	35
Current Income Taxes Payable	-	16.38	14.46	20.62	11.03	7.69
Current Unearned Revenue	109.17	107.82	117.9	130.54	147.63	142.87
Other Current Liabilities	0.59	13.09	18.92	20.14	60.38	14.14
Total Current Liabilities	217.54	246.98	266.3	263.36	411.45	372.18
Long-Term Debt	1.6	1.7	-	-	-	-
Long-Term Leases	22.14	24.46	27.75	3.69	13.55	49.32
Other Long-Term Liabilities	12.25	11.98	10.43	4.54	4.12	11.78
Total Liabilities	253.53	285.11	304.48	271.59	429.13	433.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.15	0.14	0.15	0.14	0.14	0.14
Additional Paid-In Capital	5,014	5,010	5,002	4,849	4,583	4,281
Retained Earnings	-4,291	-4,256	-4,200	-3,854	-3,200	-2,229
Treasury Stock	-57.19	-57.19	-63.26	-65.9	-58.92	-
Comprehensive Income & Other	-168.25	-162.14	-158.05	-161.53	-165.72	-207.07
Total Common Equity	497.08	535.26	580.83	768.41	1,158	1,845
Shareholders' Equity	497.08	535.26	580.83	768.41	1,158	1,845
Total Liabilities & Equity	750.61	820.38	885.31	1,040	1,587	2,279

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	45.11	43.12	52.32	12.32	50.79	86.69
Net Cash (Debt)	371.71	437.67	473.66	616.18	856.76	1,410
Net Cash Growth	-10.13%	-7.60%	-23.13%	-28.08%	-39.25%	-36.35%
Net Cash Per Share	35.09	41.17	46.02	60.18	82.45	135.33
Filing Date Shares Outstanding	10.86	10.55	10.77	10.26	10.27	10.52
Total Common Shares Outstanding	10.86	10.52	10.76	10.24	10.26	10.51
Working Capital	446.48	491.61	510.32	620.73	847.31	1,449
Book Value Per Share	45.77	50.89	53.97	75.01	112.85	175.56
Tangible Book Value	496.85	534.98	580.41	767.45	1,156	1,840
Tangible Book Value Per Share	45.75	50.86	53.93	74.92	112.66	175.07
Machinery	-	301.41	307.49	348.07	339.09	297.89
Construction In Progress	-	0.63	0.63	0.55	2.66	27.56
Leasehold Improvements	-	187.03	187.23	187.39	187.38	161.04

SEC Filings: 10-K · 10-Q